205
Participants
Start Date
April 30, 2004
Primary Completion Date
June 30, 2005
Study Completion Date
June 30, 2005
eplivanserin (SR46349)
oral administration
placebo
oral administration
Comprehensive Neuroscience, Atlanta
Jacksonville Center for Clinical Research, Jacksonville
Miami Research Assoc., Inc., Miami
Renstar Medical Research, Ocala
Physicians Research Group, Indianapolis
Wichita Clinic PA, Wichita
Westroads Medical Group, Omaha
Physicians Research Options, Ogden
Radiant Research, Phoenix
San Diego Arthritis Medical Clinic, San Diego
Seattle Rheumatology Assoc., Seattle
Sanofi-Aventis Administrative Office, Laval
Lead Sponsor
Sanofi
INDUSTRY